NCT03315754 2024-12-20Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.Steba Biotech S.A.Phase 2 Active not recruiting50 enrolled 8 charts